What is the address of MEDIPED - DR. VARGA?

The registered office of MEDIPED - DR. VARGA is located at Rue Neuve 22A, 4530 Villers-le-Bouillet.

Is MEDIPED - DR. VARGA still active?

Yes. According to the CBE (31 October 2026) MEDIPED - DR. VARGA is active, legal situation “Normale toestand”, started on 8 April 2015.

Is MEDIPED - DR. VARGA registered on Peppol?

Yes, MEDIPED - DR. VARGA is registered on the Peppol network with ID 0208:0627989183.

What is the enterprise number of MEDIPED - DR. VARGA?

The enterprise number of MEDIPED - DR. VARGA is BE0627989183.

When was MEDIPED - DR. VARGA founded?

MEDIPED - DR. VARGA was founded on 8 April 2015.

Is MEDIPED - DR. VARGA a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 8 April 2015; 5 annual accounts filed, latest fiscal year 2025.

How much profit did MEDIPED - DR. VARGA make in 2025?

MEDIPED - DR. VARGA posted a profit after taxes of € 10,040 in financial year 2025.

What is the revenue of MEDIPED - DR. VARGA?

In its most recent annual accounts (2025), MEDIPED - DR. VARGA reported revenue of € 116,181.

MEDIPED - DR. VARGA (Private Limited)

Dossier MEDIPED - DR. VARGA, printed on 1 November 2026 from databakkes.be/en/0627989183/mediped-dr-varga. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

MEDIPED - DR. VARGA from Villers-le-Bouillet, company number BE0627989183, closed financial year 2025 with a result of € 10,040 after tax. For that financial year MEDIPED - DR. VARGA recorded revenue of € 116,181 and equity of € 86,932. Compared with financial year 2024, the result moved from € 11,816 to € 10,040. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 30, 2026.

What it is worth Healthy

€ 86,932

▼ 16% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 10,040

▼ 15% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 90,262

▼ 9% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 27,114 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 33,910

▼ 24% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 26,379

▼ 22% vs 2024

€ 7,923 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 943

▼ 48% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 3,500

▲ 289% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	€ 135,810 Revenue 2022: € 135,810 First fiscal year in the series	€ 133,001 Revenue 2023: € 133,001 ▼ 2% vs 2022 (€ 135,810) Unfavourable step	€ 121,315 Revenue 2024: € 121,315 ▼ 9% vs 2023 (€ 133,001) Unfavourable step	€ 116,181 Revenue 2025: € 116,181 ▼ 4% vs 2024 (€ 121,315) Unfavourable step	▼ 4%
Gross margin	€ 43,168 Gross margin 2022: € 43,168 First fiscal year in the series	€ 29,461 Gross margin 2023: € 29,461 ▼ 32% vs 2022 (€ 43,168) Unfavourable step	€ 31,698 Gross margin 2024: € 31,698 ▲ 8% vs 2023 (€ 29,461) Favourable step	€ 29,890 Gross margin 2025: € 29,890 ▼ 6% vs 2024 (€ 31,698) Unfavourable step	▼ 6%
Profit after taxes	€ 25,366 Profit after taxes 2022: € 25,366 First fiscal year in the series	€ 19,250 Profit after taxes 2023: € 19,250 ▼ 24% vs 2022 (€ 25,366) Unfavourable step	€ 11,816 Profit after taxes 2024: € 11,816 ▼ 39% vs 2023 (€ 19,250) Unfavourable step	€ 10,040 Profit after taxes 2025: € 10,040 ▼ 15% vs 2024 (€ 11,816) Unfavourable step	▼ 15%
Equity	€ 113,945 Equity 2022: € 113,945 First fiscal year in the series	€ 116,447 Equity 2023: € 116,447 ▲ 2% vs 2022 (€ 113,945) Favourable step	€ 104,006 Equity 2024: € 104,006 ▼ 11% vs 2023 (€ 116,447) Unfavourable step	€ 86,932 Equity 2025: € 86,932 ▼ 16% vs 2024 (€ 104,006) Unfavourable step	▼ 16%
Total debts	€ 12,748 Total debts 2022: € 12,748 First fiscal year in the series	€ 6,734 Total debts 2023: € 6,734 ▼ 47% vs 2022 (€ 12,748) Favourable step	€ 40,352 Total debts 2024: € 40,352 ▲ € 33,619 vs 2023 (€ 6,734) Unfavourable step	€ 37,331 Total debts 2025: € 37,331 ▼ 7% vs 2024 (€ 40,352) Favourable step	▼ 7%
Cash	€ 125,261 Cash 2022: € 125,261 First fiscal year in the series	€ 123,091 Cash 2023: € 123,091 ▼ 2% vs 2022 (€ 125,261) Unfavourable step	€ 99,424 Cash 2024: € 99,424 ▼ 19% vs 2023 (€ 123,091) Unfavourable step	€ 90,262 Cash 2025: € 90,262 ▼ 9% vs 2024 (€ 99,424) Unfavourable step	▼ 9%
Retained profit	€ 95,345 Retained profit 2022: € 95,345 First fiscal year in the series	€ 97,847 Retained profit 2023: € 97,847 ▲ 3% vs 2022 (€ 95,345) Favourable step	€ 85,406 Retained profit 2024: € 85,406 ▼ 13% vs 2023 (€ 97,847) Unfavourable step	€ 68,332 Retained profit 2025: € 68,332 ▼ 20% vs 2024 (€ 85,406) Unfavourable step	▼ 20%
Dividend	€ 18,907 Dividend 2022: € 18,907 First fiscal year in the series	€ 16,747 Dividend 2023: € 16,747 ▼ 11% vs 2022 (€ 18,907) Unchanged	€ 24,257 Dividend 2024: € 24,257 ▲ 45% vs 2023 (€ 16,747) Unchanged	€ 27,114 Dividend 2025: € 27,114 ▲ 12% vs 2024 (€ 24,257) Unchanged	▲ 12%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 33,949 Bank debt 2024: € 33,949 Unchanged (€ 0) Unfavourable step	€ 26,379 Bank debt 2025: € 26,379 ▼ 22% vs 2024 (€ 33,949) Favourable step	▼ 22%
Balance sheet total	€ 126,693 Balance sheet total 2022: € 126,693 First fiscal year in the series	€ 123,181 Balance sheet total 2023: € 123,181 ▼ 3% vs 2022 (€ 126,693) Unchanged	€ 144,359 Balance sheet total 2024: € 144,359 ▲ 17% vs 2023 (€ 123,181) Unchanged	€ 124,262 Balance sheet total 2025: € 124,262 ▼ 14% vs 2024 (€ 144,359) Unchanged	▼ 14%

Key figures of MEDIPED - DR. VARGA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

What happened to MEDIPED - DR. VARGA?

What happened at MEDIPED - DR. VARGA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 30, 2026 New annual accounts for financial year 2025: profit of € 10,040 (▼ 15% vs 2024). Source: NBB ↗
Apr 8, 2015 New establishment in Villers-le-Bouillet. KBO
Apr 8, 2015 Start of the company according to the CBE. KBO

In short

From € 25,366 profit in 2022 to € 10,040 profit in 2025.

Paid € 23,724 in corporate taxes since 2022.

Best year ever: 2022, with € 25,366 profit.

Paid out € 87,025 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Neuve 22A

4530 Villers-le-Bouillet

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0627.989.183
VAT number: BE 0627.989.183
Registered office: Rue Neuve 22A, 4530 Villers-le-Bouillet
Names & denominations: MEDIPED - DR. VARGA
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 8 April 2015
Peppol: Active · Active since 3 Jan 2026

View on CBE Public ↗ Annual accounts (NBB) ↗

MEDIPED - DR. VARGA

Financials

What happened to MEDIPED - DR. VARGA?

Establishments

Establishment units

Details

Frequently asked questions